Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Comments on: "Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia".

Driss A.

Rev Bras Hematol Hemoter. 2013;35(1):7-8. doi: 10.5581/1516-8484.20130004. No abstract available.

2.

Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia.

Barbosa MC, Dos Santos TE, de Souza GF, de Assis LC, Freitas MV, Gonçalves RP.

Rev Bras Hematol Hemoter. 2013;35(1):29-34. doi: 10.5581/1516-8484.20130011.

3.

Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil.

Teixeira Neto PF, Gonçalves RP, Elias DB, de Araújo CP, Magalhães HI.

Rev Bras Hematol Hemoter. 2011;33(3):207-10. doi: 10.5581/1516-8484.20110055.

4.

[Iron overload in sickle cell anemia : a study of 94 patients].

Hafsia R, Belakhal F, Ben Salah N, Gouider E, Elborgi W.

Tunis Med. 2011 Jun;89(6):548-52. French.

5.

The role of iron overload on oxidative stress in sickle cell anemia.

Dos Santos TE, de Sousa GF, Barbosa MC, Gonçalves RP.

Biomark Med. 2012 Dec;6(6):813-9. doi: 10.2217/bmm.12.71.

PMID:
23227847
6.

Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.

Hagag AA, El-Farargy MS, Elrefaey S, Abo El-enein AM.

Hematol Oncol Stem Cell Ther. 2016 Mar;9(1):1-7. doi: 10.1016/j.hemonc.2015.11.005. Epub 2015 Dec 2.

7.

Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.

Tantawy AA, Adly AA, Ismail EA, Darwish YW, Ali Zedan M.

Blood Cells Mol Dis. 2014 Dec;53(4):189-93. doi: 10.1016/j.bcmd.2014.07.003. Epub 2014 Jul 25.

PMID:
25065856
8.

Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.

Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C.

Eur J Haematol. 2010 Jan 1;84(1):72-8. doi: 10.1111/j.1600-0609.2009.01342.x.

PMID:
19732137
9.
10.

Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease.

Brittenham GM, Sheth S, Allen CJ, Farrell DE.

Semin Hematol. 2001 Jan;38(1 Suppl 1):37-56. Review.

PMID:
11206960
11.

Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.

Pack-Mabien A, Brown B, Herbert DE, Haynes J Jr.

J Am Assoc Nurse Pract. 2015 Oct;27(10):591-6. doi: 10.1002/2327-6924.12221. Epub 2015 Feb 25.

PMID:
25711464
12.

Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.

Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E.

Blood. 2000 Jul 1;96(1):76-9.

13.

Iron overload in sickle cell disease.

Raghupathy R, Manwani D, Little JA.

Adv Hematol. 2010;2010:272940. doi: 10.1155/2010/272940. Epub 2010 May 17.

14.

Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia.

Belcher JD, Marker PH, Geiger P, Girotti AW, Steinberg MH, Hebbel RP, Vercellotti GM.

J Lab Clin Med. 1999 Jun;133(6):605-12.

PMID:
10360636
15.

Therapy insight: metabolic and endocrine disorders in sickle cell disease.

Smiley D, Dagogo-Jack S, Umpierrez G.

Nat Clin Pract Endocrinol Metab. 2008 Feb;4(2):102-9. doi: 10.1038/ncpendmet0702. Review.

PMID:
18212812
16.

Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P.

Br J Haematol. 2006 Oct;135(2):254-63.

17.

Two-year analysis of efficacy and safety of deferasirox treatment for transfusional iron overload in sickle cell anemia patients.

Cancado R, Olivato MC, Bruniera P, Szarf G, de Moraes Bastos R, Rezende Melo M, Chiattone C.

Acta Haematol. 2012;128(2):113-8. doi: 10.1159/000338560. Epub 2012 Jun 30.

PMID:
22760067
18.

[Establishment of macrophage model of iron overload in vitro and the injury induced by oxidative stress on macrophage with iron overload].

Cao XL, Zhao MF, Li DG, Xing Y, Zhang YC, Chen J, He XY, Cui R, Meng JX, Xiao X, Mu J, Jiang YY, Wu RM.

Zhonghua Yi Xue Za Zhi. 2016 Jan 12;96(2):129-33. doi: 10.3760/cma.j.issn.0376-2491.2016.02.012. Chinese.

PMID:
26792697
19.

Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease.

Alsultan AI, Seif MA, Amin TT, Naboli M, Alsuliman AM.

Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):527-38.

PMID:
20712260
20.

[Iron status in 72 Congolese patients with sickle cell anemia].

Tshilolo L, Zita MN, Ngiyulu R, Kayembe Nzongola D.

Med Sante Trop. 2016 Jan-Mar;26(1):83-7. doi: 10.1684/mst.2016.0535. French.

Supplemental Content

Support Center